EMJ Podcast: Insights For Healthcare Professionals

OA is no longer just a "wear and tear" condition. It's a complex, multifactorial disease shaped by inflammation, biomechanics, genetics, and lifestyle. Early diagnosis and timely intervention can shift the course, preventing progression and unlocking the body's potential for self-healing. Today's OA care is moving beyond symptom management. Personalised treatment, interdisciplinary support, and pa...

In this first deep dive, Stuart Elborn reflects on the major scientific breakthroughs of his career, and how laboratory discoveries have transformed cystic fibrosis care. He discusses lessons from pivotal CTFR modulator trials, the role of consensus guidelines, and the challenges of caring for an ageing cystic fibrosis population.

Stuart Elborn joins the EMJ Podcast for a quickfire discussion on modern cystic fibrosis care. From CFTR modulators to antimicrobial resistance and personalised medicine, he shares concise insights into the biggest shifts shaping cystic fibrosis outcomes today.

Byrne discusses Dova's recent Late Breaker at the United European Gastroenterology (UEG) Week 2025, where AI re-analysis uncovered treatment effects missed by human readers. He explains how AI may soon become integral to clinical trial design, regulatory review, and drug approval, while predicting how AI-human partnerships will define the future of gastroenterology. Timestamps: 01:05 – AI in the T...

Bias, privacy, and ethics take centre stage as Byrne discusses how to build trustworthy AI systems. From data transparency to global access, he shares practical steps to ensure equitable innovation and reflects on the fears clinicians express about integrating AI in their daily workflow. Timestamps: 01:09 – Addressing bias and inequity 03:10 – Data privacy and regulation 04:40 – Trust and clinical...

In this episode,  Rob Jones , Professor and Honorary Consultant in Medical Oncology at the University of Glasgow,  UK,   joins  us to discuss his journey into oncology, the future of the specialty, and the evolving treatment landscape for genitourinary cancers.  From clinical trial design and emerging therapies  to  European Society for Medical  Oncology ( ESMO )  2025 takeaways  and  thoughts on ...

In this first deep dive, Byrne explores how AI is revolutionising inflammatory bowel disease care. He discusses the DovaVision™ UC (Dova Health Intelligence, Vancouver, Canada) Mayo Endoscopic Score developed with the Mayo Clinic; the power of multimodal AI in combining colonoscopy, ultrasound, and lab data; and how AI reduces interobserver variability in disease scoring. Timestamps: 01:04 – The l...

Michael Byrne joins the EMJ Podcast to tackle rapid-fire questions on AI's role in gastroenterology. From clinical misconceptions to the biggest breakthroughs in endoscopy, discover how intelligent tools are redefining precision medicine in inflammatory bowel disease.

In this special countdown episode, the EMJ Podcast team looks back at the 10 highest-performing episodes of 2025. Spanning neurology, cardiology, gastroenterology, women's health, respiratory medicine, and digital innovation, these conversations captured the topics that mattered most to clinicians worldwide. From chronic pain and anxiety to glucagon-like peptide-1 therapies, antimicrobial stewards...

In this special two-part episode of  Onc Now , Catherine Glass returns to take you through the incredible lineup of guests from 2025. From award winners to pioneering clinicians and researchers, this podcast has spotlighted some of the leading voices in   oncology. Explore their most impactful insights and hear how recent advances are shaping clinical practice and future research.   Timestamps:   ...

  In this third and final deep-dive episode, Nicholas Simmonds highlights the importance of collaborative networks, such as the European Cystic Fibrosis Society (ECFS) Clinical Trials Network, in enabling global clinical trials. He also emphasises the central role of the patient voice in developing new therapies, using CFTR modulators as a key example. Timestamps: 00:00 – Introduction 00:55 – ECFS...

How is cystic fibrosis diagnosis evolving? In this second deep dive, Nicholas Simmonds explores advances in diagnostic tools and shares his experience with the CF registry, highlighting its value as a powerful resource for tracking long-term treatment effectiveness. A must-listen for clinicians and anyone interested in how cystic fibrosis is diagnosed, and how progress is monitored over time. Time...

Nicholas Simmonds joins host Saranya Ravindran for a deep dive into how adult cystic fibrosis (CF) care is evolving. Drawing on decades of experience, he discusses the major shifts in adult CF management, the vulnerable transition from paediatric to adult services, and strategies that ensure a smooth handover. Explore how longer survival brings new challenges, from fertility to mental health and e...

In this rapid-fire episode, Nicholas Simmonds answers key questions about cystic fibrosis (CF), from common misconceptions and the value of registry data to CF testing, and the transition from paediatric to adult care. Perfect for listeners short on time.

In the final part of this deep dive series, David Heymann looks ahead to future threats, from antimicrobial resistance to zoonotic spillovers, and the innovations that offer hope. He discusses next-generation diagnostics and vaccines, the rise of the One Health approach, and the need for better global financing and communication strategies. The episode closes with guidance for future public health...

In Part 2 of this deep dive series, David Heymann examines how global surveillance systems operate, why international coordination remains difficult, and how eradication efforts, such as those for polio, continue to strengthen health infrastructures. He reflects on the realities of responding in low-resource settings and the tension between rapid emergency interventions and sustainable system-buil...

In this special two-part episode of  Onc  Now , Catherine Glass takes you through the incredible line-up of guests from 2025. From  award winners  to pioneering clinicians and researchers, this podcast has spotlighted some of the leading voices in the field of  oncology . Explore their most impactful insights and hear how recent advances are shaping clinical practice and future research.   Timesta...

David Heymann joins host   Jonathan Sackier to reflect on the defining outbreaks that shaped modern epidemiology. He recounts early Ebola investigations, compares SARS-CoV-1 with SARS-CoV-2, and revisits the smallpox eradication campaign. This episode offers rare insights into the field experiences that transformed global preparedness. Timestamps: 00:00 – Introduction 01:07 – Ebola 05:51 – SARS-Co...

In this quickfire episode, David Heymann answers essential questions about outbreak response, pandemic preparedness, and the future of global health. From the biggest misconceptions about infectious diseases to the threats we're overlooking, this introduction sets the stage for the full series.

In the final instalment of this episode on paediatric cystic fibrosis, Lisa Saiman explores the global inequities that persist, noting how progress is hindered by limited access to advanced antimicrobial resistance prevention tools such as sequencing and pathogen identification. She emphasises the need for strengthened international collaboration to help bridge these gaps. Timestamps : 00:00 – Int...

How can the threat of antimicrobial resistance be mitigated? In this second deep-dive episode, Lisa Saiman shares insights into the value of antibiotic stewardship and the nuance of microbial susceptibility testing in patients with cystic fibrosis. A must-listen for anyone curious about the overlap between cystic fibrosis and pathogen resistance. Timestamps : 00:00 – Introduction 03:30 – Antimicro...

Lisa Saiman joins host Saranya Ravindran to discuss infection prevention in children with cystic fibrosis, exploring evolving hospital and clinical practices, key respiratory pathogens, and practical strategies to reduce infection risk at home. Learn about how the risk of infection affects the day-to-day lives of patients with cystic fibrosis. Timestamps: 00:00 – Introduction 01:05 – Prevention im...

In this rapid-fire episode, Lisa Saiman answers key questions about infections in children with cystic fibrosis, from everyday prevention measures to the threat of antimicrobial resistance. Perfect for listeners short on time but eager to boost their paediatric cystic fibrosis knowledge in just a few short minutes.

In this episode, Catherine Glass is joined by Anna Minchom, Clinical Scientist at the Drug Development Unit at the Royal Marsden Hospital and the Institute of Cancer Research, London, UK. In a highly informative discussion, Minchom explains the drug development process, key considerations in designing and conducting a trial, and the challenges in drug resistance.   Timestamps :        00:00 – Intr...

What does  body dysmorphic disorder ( BDD )  look like in young people? In Part 3, Katharine Phillips discusses developmental differences in symptoms across children, adolescents, and diverse cultural or gender groups. She outlines early warning signs, risk factors that shape long-term outcomes, and how clinicians can distinguish BDD from related disorders such as  obsessive - compulsive disorder...